Clinically achievable concentration of the mTOR inhibitors, rapamycin and RAD001, reduced cellular proliferation and radiosenstized pituitary adenoma cells, at least in part, by inducing G1 growth arrest. The gene discussed is MTOR; the disease is pituitary gland adenoma.